Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 9Recurrence 4Breast Neoplasms 4Advanced Solid Tumors 4Solid Tumor 3Lymphoma, Non-Hodgkin 3Lymphoma 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Medical Oncology 2Lymphoma, Follicular 2Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumours 1Solid Tumour 1Solid Tumors 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma 1Rhabdoid Tumor 1Refractory or Relapsed Solid Tumors 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Mesothelioma 1

Interventions

Biopsy 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2polyphenon E 1plecanatide 1linaclotide 1gluconic acid 1Specimen Handling 1Itraconazole 1Esomeprazole 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1Endoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Barrett Esophagus × Itraconazole × Clear all
NCT05609253 2025-08-08

Itraconazole to Prevent Recurrent Barrett's Esophagus

University of Kansas Medical Center

Phase 1 Active not recruiting
10 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡